IP Library Granted Patent US 10,428,124
Granted Patent B2
US 10,428,124 · App. 14/375,980 · Granted Oct 1, 2019

Timothy grass allergens and methods and uses for immune response modulation

Inventors: Alessandro Sette (La Jolla, CA); Veronique Schulten (San Diego, CA); Howard Grey (La Jolla, CA); Bjoern Peters (San Diego, CA); Jason Greenbaum (San Diego, CA)
Assignee: La Jolla Institute For Allergy And Immunology
C07K14/415A61K39/36A61K38/00A61K2039/543A61K2039/55505
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,428,124
App. No.
14/375,980
Granted
Oct 1, 2019
Kind
B2
Abstract

The invention relates to Timothy Grass proteins and peptides, subsequences, portions, homologs, variants and derivatives thereof, and methods and uses of Timothy Grass proteins and peptides. Methods include, for example, modulating an immune response; protecting a subject against or treating a subject for an allergic response, allergic disorder or allergic disease; and inducing immunological tolerance to the allergen in a subject.

Claims (9)

1. A method for increasing immunological tolerance against grass pollen in a subject, the method comprising administering at least once to a subject an effective amount of a peptide comprising at least one T-cell epitope, said peptide consisting of

a) an amino acid sequence selected from the group consisting of SEQ ID NOS: 854, 855, and 857-868

wherein said peptide induces, elicits or stimulates production of interleukin-5 or interferon-gamma production in peripheral blood mononuclear cells from grass allergic subjects following contact with said peptide.

2. The method of claim 1 , wherein said production of interleukin-5 or interferon-gamma in peripheral blood mononuclear cells treats grass pollen allergy in a subject having a grass pollen allergy.

3. The method according to claim 1 , wherein the peptide further elicits, stimulates, promotes, induces or enhances a T cell response following administration to said subject.

4. A method for increasing immunological tolerance against grass pollen in a subject, the method comprising administering at least once to a subject an effective amount of a protein consisting of:

a) an amino acid sequence selected from the group consisting of SEQ ID NOS:177-186

wherein said protein induces, elicits or stimulates production of interleukin-5 or interferon-gamma production in peripheral blood mononuclear cells from grass allergic subjects following contact with said protein.

5. The method of claim 4 , wherein said production of interleukin-5 or interferon-gamma in peripheral blood mononuclear cells treats grass pollen allergy in a subject having grass pollen allergy.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2014
From: SETTE, ALESSANDRO; SCHULTEN, VERONIQUE; GREY, HOWARD; PETERS, BJOERN; GREENBAUM, JASON
To: LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
Reel/Frame 034115/0109 →
Continuity (3)
Provisional Application 61596156 · Feb 7, 2012
Provisional Application 61734886 · Dec 7, 2012
Related Publication 20150023992A1 · Jan 22, 2015